INS and diabetes mellitus: A B cell transgenic mouse, expressing a fixed heavy-chain B cell receptor (BCR) with potential for insulin binding, had an increased frequency of anti-insulin B cells in a polyclonal repertoire (VH125) and accelerated diabetes onset [7].